About
Lijun completed her Honours in Laboratory Medicine at the University of South Australia and earned a Graduate Certificate in Bioinformatics from the University of Queensland. Since 2022, Lijun has been conducting her PhD studies in Dr Olga Kondrashova’s group at QIMR Berghofer. She is investigating the mechanisms that drive epigenetic changes and subsequent treatment resistance in cancer with homologous recombination deficiency.
Research Projects
Current Research Projects
Overcoming PARP inhibitor resistance in ovarian and breast cancer
Publications
Xu, L. et al. "High-level tumour methylation of BRCA1 and RAD51C is required for homologous recombination deficiency in solid cancers." NAR Cancer (2024).